Advertisement

Topics

Netherlands Genomics Initiative NGI Company Profile

15:43 EDT 21st September 2017 | BioPortfolio

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further strengthening of the knowledge base (research, technology and education).

Location

P.O. Box 93035
The Hague
2509 AA
Netherlands

Contact

Phone: 31 70 344 0672, +31 70 344 0640
Fax: 31 70 344 0632
Email: info@genomics.nl


News Articles [982 Associated News Articles listed on BioPortfolio]

The Launch Of One Belt, One Road Initiative, A Precision Medicine Collaboration With

ULAANBAATAR, MONGOLIA and SHANGHAI, CHINA--(Marketwired - June 09, 2017) - CloudHealth Genomics, one of the world's fastest growing genomics-based precision medicine and scientific wellness sol...

How about 2 million? DNAnexus joins AstraZeneca’s new genomics initiative

“The thing that’s difficult to grasp from the outside is the velocity of knowledge gain in genomics. It is just amazing,” marveled Richard Daly, CEO of DNAnexus.

Front Line Genomics Release: Festival Of Genomics Returns To San Diego???Genomics Wonderland

  Life Sciences Jobs   ...

Recognitions for Contributions in Genomics by Dan David Prize Awards

Recognitions for Contributions in Genomics by Dan David Prize Awards Reporter: Aviva Lev-Ari, PhD, RN   The Source for this List is a Search for “Genomics” on the Dan David Prize webs...

UC Santa Cruz Genomics Institute Joins International Human Cell Atlas Initiative

  Life Sciences Jobs   ...

Researchers discover a crucial gene involved in the development of the placenta

A massive genomics study of people with intellectual disabilities performed in the Netherlands points to patient mutations in the TLK2 gene.

FILM: What Next for Genomics?

This film documents the Progress Educational Trust/Genomics England event 'What Next for Genomics? Providing Answers, Changing Lives, Transforming the NHS', which launched the Chief Medical Officer's ...

Economic Study Ranks San Diego Near Top in Genomics Innovation

An economic impact study of San Diego’s emerging genomics industry counted 115 genomics-related companies operating in the region that directly employ over 10,000 people, and drive about $5.6 billio...

Clinical Trials [388 Associated Clinical Trials listed on BioPortfolio]

Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response to IVF Drugs

The purpose of this study is to evaluate the effectiveness of a modified natural cycle in patients with previous poor response to infertility drugs, prior to proceeding to oocyte donation ...

Resuscitation Outcomes in the Netherlands

The Resuscitation Outcomes in the Netherlands - study assesses one-year survival and quality of life after In-Hospital Cardiac Arrest(IHCA). It's design is a multicenter prospective observ...

Quality Initiative in Rectal Cancer (QIRC) Trial

The Quality initiative in rectal cancer (QIRC) trial will test if a strategy designed to positively influence surgeon practice can decrease hospital rates of permanent colostomy and local ...

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

The main purpose of this study is to evaluate safety and effectiveness of the treatment of multiple myeloma with bortezomib in daily practice in the Netherlands.

Eisenmenger Quality Enhancement Research Initiative

Eisenmenger Quality Enhancement Research Initiative (QuERI) is a multi-center, observational, US-based longitudinal program, with enrollment of consecutive Eisenmenger patients who meet en...

Companies [841 Associated Companies listed on BioPortfolio]

Netherlands Genomics Initiative NGI

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further stre...

InteRNA Genomics

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and based in Bilthoven, the Netherlands, offers services and software for processing, analyzing and presenting ultra-high-throughpu...

Dyadic Nederland BV

Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, the Netherlands that is dedicated to research and development activities for the benefit of Dyadic, ...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Netherlands Genomics Initiative NGI" on BioPortfolio

We have published hundreds of Netherlands Genomics Initiative NGI news stories on BioPortfolio along with dozens of Netherlands Genomics Initiative NGI Clinical Trials and PubMed Articles about Netherlands Genomics Initiative NGI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Netherlands Genomics Initiative NGI Companies in our database. You can also find out about relevant Netherlands Genomics Initiative NGI Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record